An interventional study of Dedicated and coordinated e-follow-up. in Breast Cancer, sponsored by Institut Claudius Regaud. Completed at 1 site in France. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-08-06.
Sponsored by Institut Claudius Regaud · Not applicable, Interventional, and Health services research
This is a monocentric, prospective cohort study evaluating the feasibility of a perioperative e-follow-up protocol in patients with ambulatory surgery for breast cancer.
This protocol will be based on:
Patients will be followed 8 days before the surgery until 30 days after the surgery of breast cancer.
Exclusion Criteria:
Other: Dedicated and coordinated e-follow-up.
In pre- and post-surgery: * Completion of questionnaires using an electronic tool, * Telephone follow-up if necessary between the nurse and the patient.
Rate of patients without failure to the e-follow-up. A failure is defined by absence of connection to the electronic tool and the mismatch between the alert level and severity of complications.
Time frame: 1.5 months by patient
Patient satisfaction to the e-follow-up.
Satisfaction will be evaluated by questionnaire.
Time frame: 1.5 months by patient
The rate of patients who discontinue the study 8 days before the surgery.
Time frame: 1.5 months by patient
The number of unplanned visits into the Center after ambulatory surgery in the first 24 hours and during the first 30 days will be assessed for each patient.
Time frame: 1.5 months by patient
Rate of patients with at least one unplanned visit.
Time frame: 1.5 months by patient
The time spent by the dedicated nurse for the follow-up protocol management.
It will be defined as the sum of the time spent at different stages: initial training of patients, tracking of the connections to the tool, tracking of the alerts and telephone contacts.
Time frame: 1.5 months by patient
This study is completed, as verified in Aug 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Institut Claudius Regaud